Wolk DA - Search Results

1

Can MRI screen for CSF biomarkers in neurodegenerative disease?

McMillan CT, Avants B, Irwin DJ, Toledo JB, Wolk DA, Van Deerlin VM, Shaw LM, Trojanoswki JQ, Grossman M. McMillan CT, et al. Among authors: wolk da. Neurology. 2013 Jan 8;80(2):132-8. doi: 10.1212/WNL.0b013e31827b9147. Epub 2012 Dec 26. Neurology. 2013. PMID: 23269595 Free PMC article.

2

Amyloid imaging in mild cognitive impairment subtypes.

Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, De-Kosky ST. Wolk DA, et al. Ann Neurol. 2009 May;65(5):557-68. doi: 10.1002/ana.21598. Ann Neurol. 2009. PMID: 19475670 Free PMC article.

3

Update on amyloid imaging: from healthy aging to Alzheimer's disease.

Wolk DA, Klunk W. Wolk DA, et al. Curr Neurol Neurosci Rep. 2009 Sep;9(5):345-52. doi: 10.1007/s11910-009-0051-4. Curr Neurol Neurosci Rep. 2009. PMID: 19664363 Free PMC article. Review.

4

Fractionating verbal episodic memory in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative. Wolk DA, et al. Neuroimage. 2011 Jan 15;54(2):1530-9. doi: 10.1016/j.neuroimage.2010.09.005. Epub 2010 Sep 9. Neuroimage. 2011. PMID: 20832485 Free PMC article.

5

Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.

Wolk DA, Grachev ID, Buckley C, Kazi H, Grady MS, Trojanowski JQ, Hamilton RH, Sherwin P, McLain R, Arnold SE. Wolk DA, et al. Arch Neurol. 2011 Nov;68(11):1398-403. doi: 10.1001/archneurol.2011.153. Epub 2011 Jul 11. Arch Neurol. 2011. PMID: 21747004 Free PMC article.

6

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A. Weintraub D, et al. Among authors: wolk da. Brain. 2012 Jan;135(Pt 1):170-80. doi: 10.1093/brain/awr277. Epub 2011 Nov 21. Brain. 2012. PMID: 22108576 Free PMC article.

7

Neurodegeneration across stages of cognitive decline in Parkinson disease.

Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM. Weintraub D, et al. Among authors: wolk da. Arch Neurol. 2011 Dec;68(12):1562-8. doi: 10.1001/archneurol.2011.725. Arch Neurol. 2011. PMID: 22159053 Free PMC article.

8

MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults.

Dickerson BC, Wolk DA; Alzheimer's Disease Neuroimaging Initiative. Dickerson BC, et al. Among authors: wolk da. Neurology. 2012 Jan 10;78(2):84-90. doi: 10.1212/WNL.0b013e31823efc6c. Epub 2011 Dec 21. Neurology. 2012. PMID: 22189451 Free PMC article.

9

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.

Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E; AAB-001 201/202 Investigators. Blennow K, et al. Arch Neurol. 2012 Aug;69(8):1002-10. doi: 10.1001/archneurol.2012.90. Arch Neurol. 2012. PMID: 22473769 Clinical Trial.

10

Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.

Wolk DA, Detre JA. Wolk DA, et al. Curr Opin Neurol. 2012 Aug;25(4):421-8. doi: 10.1097/WCO.0b013e328354ff0a. Curr Opin Neurol. 2012. PMID: 22610458 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters